10-K: NorthStar Healthcare Income Announces Merger Agreement with Welltower Affiliate in 10-K Filing

NorthStar Healthcare Income reveals a merger agreement with Compound Holdco LLC, an affiliate of Welltower Inc., in its annual 10-K filing, projecting a closing in the second quarter of 2025.

Summary

• NorthStar Healthcare Income, Inc. has entered into a merger agreement with Compound Holdco LLC, an affiliate of Welltower Inc., where stockholders will receive $3.03 per share in cash.
• The merger, unanimously approved by NorthStar's Board, is expected to close in the second quarter of 2025, pending stockholder approval and other customary conditions.
• The company's primary objective is to maximize value and generate liquidity for stockholders, with a focus on growing operating income and pursuing strategic disposition opportunities.
• As of December 31, 2024, NorthStar's seniors housing investments portfolio includes 42 properties, comprising independent living facilities (ILFs), assisted living facilities (ALFs), and memory care facilities (MCFs).
• The company operates through two reportable segments: operating investments and net lease investments, with the latter being designated as held for sale and completed in January 2025.
• NorthStar sold its investment in Trilogy for $254.0 million and two properties within the Rochester portfolio for $14.8 million during the year ended December 31, 2024.
• The company's average occupancy for its operating investments improved to 90.1% as of December 31, 2024, compared to 88.1% in the prior year.
• Net operating income (NOI) increased by 16.9% on a same-store basis during the year ended December 31, 2024, driven by improved occupancy and higher market rates.
• The company had approximately $328.5 million of unrestricted cash as of March 12, 2025, a significant portion of which has been placed in interest yielding money market funds invested in short-term U.S. government securities.
• The Board approved an estimated value per share of $2.96 for the company's common stock as of June 30, 2024, reflecting a year-over-year increase of $0.32 per share.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the announcement of the merger agreement, improved operating performance, and strong liquidity position. However, risks associated with the merger and macroeconomic conditions temper the overall outlook.

Positives

• The merger agreement provides a clear path to liquidity for stockholders at a premium of $3.03 per share.
• Improved occupancy rates and strategic capital expenditures have driven growth in net operating income.
• The sale of the Trilogy investment generated significant net proceeds of $254.0 million.
• The company has a strong liquidity position with $328.5 million in unrestricted cash.
• The estimated value per share increased by $0.32 year-over-year, reflecting improved asset values.

Negatives

• The merger is subject to customary closing conditions, and there is no guarantee that it will be consummated.
• The company is subject to restrictions on the conduct of its business prior to the consummation of the merger.
• The company has a history of net operating losses, which may impact its ability to make distributions in the future.
• The company's borrowings are concentrated with Fannie Mae, which may limit flexibility in modifying or extending loans.
• The company's share repurchase program has been suspended, limiting stockholders' ability to sell their shares.

Risks

• The merger may not be consummated, and the company may be liable for significant termination amounts.
• Macroeconomic trends, including inflation and rising interest rates, may adversely affect the company's business and financial results.
• The company is exposed to operational risks at its properties and is dependent on the managers of these properties.
• The company may not be able to generate sufficient cash flow to meet its debt service obligations.
• The company's ability to refinance borrowings and/or sell assets will be significantly impacted by market conditions.

Future Outlook

The company expects the merger to close in the second quarter of 2025. If the merger is not completed, the Board will evaluate special distributions in connection with asset sales and other realizations of investments.

Industry Context

The announcement comes amid generally favorable market conditions for seniors housing, with average occupancy increasing and strong supply and demand fundamentals.

Comparison to Industry Standards

• The document does not provide a direct comparison to industry standards.
• However, it mentions that average occupancy for the seniors housing industry increased to 87.2% for the fourth quarter of 2024, surpassing the pre-pandemic average of 87.1% in March 2020.
• This suggests that NorthStar Healthcare Income's occupancy rate of 90.1% for its operating investments is above the industry average.

Related Party Transactions

• The company recognized property management fees and other incentive fees expense of $13.4 million to Solstice related to the Winterfell portfolio.
• In June 2023, the Company sold its 14% interest in Healthcare GA Holdings, General Partnership, which indirectly owned 48 care homes across the United Kingdom (Diversified US/UK), and its 6% interest in Eclipse Health, General Partnership, which indirectly owned 34 seniors housing facilities (Eclipse), together with $1.1 million in cash, to its Former Sponsor, who is affiliated with the majority partner of each joint venture, for all of the Companys equity securities held by the Former Sponsor and its affiliates, including 9,709,553 shares of common stock of the Company, 100 common units in the Operating Partnership and 100 special units in the Operating Partnership.

Stakeholder Impact

• Stockholders are expected to receive $3.03 per share in cash upon consummation of the merger.
• Employees may be affected by the merger, but the details are not specified in the document.
• The impact on customers, suppliers, and creditors is not explicitly discussed in the document.

Next Steps

• Stockholders will be asked to vote to approve the merger at a special meeting.
• The company will work to satisfy the customary closing conditions for the merger.
• If the merger is not completed, the Board will evaluate special distributions in connection with asset sales and other realizations of investments.

Key Dates